PEN
Penumbra, Inc.Healthcare · $12.5B market cap
Verdict
Share price
$317.55
close of Oct 3, 2026
Fair value
$73.19
Sticker Price
Payback Price
$29.28
buy price
PEN is Overpriced: at $317.55 it trades 334% above its fair value of $73.19. Its buy price (Payback Price) is $29.28, 91% below today's price. Business quality is strong: 4 of 5 key numbers clear the 10% bar.
How we valued it
Buffett Normalized. A profitable, growing business, so we project its earnings 10 years ahead and work out what that is worth today.
Business quality
4 of 5 clear the 10% bar. What are the Big Five?
Follow PEN
Get notified when it reaches its buy price of $29.28. Free.
Create a free accountInsider activity
Since Aug 17, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter
Other filings
About Penumbra, Inc.
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT…
Medical - Devices
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works